Fibromyalgia: An Environmental Scan

Table of Contents


Abeles, M., Solitar, B., Pillinger, MH. et al. 2008. “Update on fibromyalgia therapy.” The American Journal of Medicine 121:555-561.

Albin, JN., Neumann, L., and Dan Buskila. 2008. “Pathogenesis of fibromyalgia – A review.” Joint Bone Spine75:273-279.

Albin, JN., Shoenfeld, Y., Bushila, D. 2006. “Fibromyalgia, infection and vaccination: Two more parts in the etiological puzzle.” Journal of Autoimmunity 27:145-152.

Arnold, Lesley M. 2000. “Antidepressant treatment of fibromyalgia: A meta-analysis and review” (2): 104Psychosomatics 104-113.

Aryeh, M., Pillinger, Micheal H., Solitar, Bruce M. and Micha Abeles. 2007. “Narrative Review: The Pathophysiology of Fibromyalgia — Abeles et al. 146 (10): 726 — Annals of Internal Medicine.” Annals of Internal Medicine 146:726-734.

Baldursdottir, S. 2008. “Juvenile primary fibromyalgia syndrome–review.” Laeknabladid 94:463-72.

Bradshaw D, Nakamura Y, and Chapman C. 2005. “National Institutes of Health grant awards for pain, nausea and dyspnea research: An assessment of funding patterns in 2003” Journal of Pain. 6(5):277–293.

Bannwarth, Bernard et al. 2009. “Fibromyalgia syndrome in the general population of France: a prevalence study.” Joint, Bone, Spine: Revue Du Rhumatisme 76:184-187.

Bertsias, G et al. 2008. “EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.” Annals of the Rheumatic Diseases 67:195-205.

Borigini, Mark. 2009. “Fibromyalgia Update From The American College Of Rheumatology Annual Meeting, 2009 | Psychology Today.” (Accessed November 9, 2009).

Branco, J. C et al. 2009. “Prevalence of Fibromyalgia: A Survey in Five European Countries.” in Seminars in Arthritis and Rheumatism.

Breivik, H, S Hattori, S Moulin, and E Dwight. 2005. “Prevalence and impact of chronic pain: a systematic review of epidemiological studies on chronic pain.” in International Association for the Study of Pain. Sydney, Australia: WHO (Accessed October 30, 2009).

Breivik, H., B. Collett, V. Ventafridda, R. Cohen, and D. Gallacher. 2006. “Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment.” European Journal of Pain 10:287–333.

Burgmer, Markus, Markus Gaubitz, Carsten Konrad, and Marco Wrenger. 2009. “Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia.” Journal of Biobehavioural Medicine 71:566-573.

Buskila, D., and Piercarlo Sarzi-Puttini. 2006. “Arthritis Research & Therapy Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome.” Arthritis Research and Therapy 8:218.

Carville, S.F., Arendt-Nielsen, S., Biddal, H. et al. 2008. “EULAR evidence-based recommendations for the management of fibromyalgia syndrome” 67 (4): 536 Annals of Rheumatic Diseases 67:536-541.

Castro-Lopez, J., Borgeat,  A., Collett, B., and Rhodin, A. 2005. “Legal and regulatory frameworks governing opioid prescribing across Europe.” in International Association for the Study of Pain. Sydney, Australia.

Cervera, R. 2006. “Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the “Euro-Lupus Project”.” Autoimmunity Reviews 5:180–186.

Chakrabarty, Sangita, and Roger Zoorob. 2007. “Fibromyalgia.” American Family Physician 76:247-254.

Clauw, D. J, and L. J Crofford. 2003. “Chronic widespread pain and fibromyalgia: What we know, and what we need to know.” Best Practice & Research Clinical Rheumatology 17:685–701.

Dadabhoy, D., and Daniel J. Clauw. 2006. “Nature Clinical Practice Rheumatology | Therapy Insight: fibromyalgia a different type of pain needing a different type of treatment | Article.” Nature Clinical Practice Rheumatology 2:364-372.

Gatchel, R. J, Y. B Peng, M. L Peters, P. N Fuchs, and D. C Turk. 2007. “The biopsychosocial approach to chronic pain: scientific advances and future directions.” Psychological bulletin 133:581.

Glabus, MF, R Simpson, and JC Patterson. 2009. “Changes in gray matter density in fibromyalgia: Correlation With dopamine metabolism.” Journal of Pain 10:609-618.

Hoffman, DL. and EM. Dukes. 2008. “The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12.” International Journal of Clinical Practice62:115-126.

Kellow, J. E et al. 2006. “Applied principles of neurogastroenterology: physiology/motility sensation.”Gastroenterology 130:1412–1420.

Krypel, Linda L. 2009. “Fibromyalgia: A review of its pathophysiology and drug treatment.” Journal of Pharmacy Practice 22:6-16.

Lombardi, Vincent C et al. 2009. “Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome.” SCIENCE 326:585-589.

Longstreth, G. F et al. 2006. “Functional bowel disorders.” Gastroenterology 130:1480–1491.

Mäkelä, M. O. 1999. “Is fibromyalgia a distinct clinical entity? The epidemiologist’s evidence.” Best Practice & Research Clinical Rheumatology 13:415-419.

Marcus, Dawn. 2009. “Fibromyalgia.” in Chronic Pain A Primary Care Guide to Practical Management.Current Clinical Practice. Humana Press.

Marcus, Dawn. 2008.  “Lifestyle and Psychological Issues.” (Accessed July 14, 2009).

Marcus, Dawn. 2009. “Summary of Pain Management Issues: Frequent Concerns in Treating Chronic Pain Patients. (Accessed July 14, 2009).

Martinez-Lavin, M. 2007. “Arthritis Research & Therapy Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgia.” Arthritis Research and Therapy 9:216.

Max, M. B. 2003. “How to move pain and symptom research from the margin to the mainstream.” Journal of Pain 4:355–360.

May, A. 2005. “Cluster headache: pathogenesis, diagnosis, and management.” The Lancet 366:843–855.

Mease, P. 2005. “Fibromyalgia syndrome: review of clinical presentation” J Rheumatol Suppl. 2005 Aug;75:6-21 6-21.

Miaskowski, C.; Cleary, J.; Burney, R.; Coyne, P.; Finley, R.; Foster, R.; Grossman, S.; Janjan, N.; Ray, J.; Syrjala, K.; Weisman, S.; and Zahrbock, C. (2005).  Guideline for the Management of Cancer Pain in Adults and Children, APS Clinical Practice Guidelines Series, No. 3.  Glenview, IL: American Pain Society. Page 4.

Millea, Paul J., and Richard L. Holloway. 2000. “Treating Fibromyalgia.” American Family Physician 62:1575-82.

Monstad, P. 2009 “Microvascular decompression as a treatment for cranial nerve hyperactive dysfunction – a critical view.” Acta Neurologica Scandinavica 115:30-33.

Nampiaparampil, D. E, and R. H Shmerling. 2004. “A review of fibromyalgia.” Am J Manag Care 10:794–800.

Pain & Policy Studies Group.  Achieving Balance in State Pain Policy: A Progress Report Card (third edition). University of Wisconsin Paul P. Carbone Comprehensive Cancer Center.  Madison, Wisconsin, 2007.

Perrot, S., Dickenson, AH., and Robert Bennett. 2008 “Fibromyalgia: Harmonizing science with clinical practice considerations” Pain Practice 8:177-189.

Perrot, Serge, Anthony H Dickenson, and Robert M Bennett. 2008. “Fibromyalgia: harmonizing science with clinical practice considerations.” Pain Practice: The Official Journal of World Institute of Pain 8:177-189.

Peterson, EL. 2007. “Fibromyalgia management of a misunderstood disorder” Journal of the American Academy of Nurse Practitioners 19:341-348.

Podolecki, T., Podolecki, A., Hrycek, A. 2009. “Fibromyalgia: Pathogenetic, diagnostic and therapeutic concerns.” Polskie Archiwum Medycyny Wewnetrznej 119:157-161.

Schürks, Markus, Hans-Christoph Diener, and Peter Goadsby. 2008. “Update on the prophylaxis of migraine.” Current Treatment Options in Neurology 10:20-29.

Spiller, R et al. 2007. “Guidelines on the irritable bowel syndrome: mechanisms and practical management.”Gut 56:1770-1798.

Taylor, Allyn L. 2007. “Addressing the global tragedy of needless pain: Rethinking the United Nations single convention on narcotic drugs.” Journal of Law, Medicine and Ethics 35:556-571.

Tunks, E. R, J. Crook, and R. Weir. 2008. “Epidemiology of chronic pain with psychological comorbidity: prevalence, risk, course, and prognosis.” Can J Psychiatry 53:224–234.

Valença, M. M, F. L Medeiros, H. A Martins, R. M Massaud, and M. F.P Peres. 2009. “Neuroendocrine dysfunction in fibromyalgia and migraine.” Current Pain and Headache Reports 13:358–364.

van’t Leven, Marjokein, Gerhard A. Zielhuis, Jos W. van der Meer, Andre L. Verbeek, and Gijs Bleijenberg. 2009. “Fatigue and chronic fatigue syndrome-like complaints in the general population.” European Journal of Public Health Online Publication. (Accessed November 13, 2009).

Vigna-Perez, M. et al. 2006. “Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study.” Arthritis Research and Therapy 8:83.

Wallace, Daniel Jeffery, and Daniel J Clauw. 2005. Fibromyalgia & Other Central Pain Syndromes. 1st ed. Philadelphia, PA: Lippincott Williams and Wilkins.

Weir, Peter T., Harlan, Gregory A., Nkoy, F. et al. 2006. “The incidence of fibromyalgia and its associated comorbidities: A population-based retrospective cohort study based on international classification of diseases, 9th Revision Codes.” Journal of Clinical Rheumatology 12:124-128.

Wood, Patrick. 2008. “Fibromyalgia – The Sound of Distant Thunder | Neurology.” US Neurological Disease 2. (Accessed May 21, 2009).

Wyller, Vegard Bruun. 2007. “The chronic fatigue syndrome: an update.” Acta Neurologica Scandinavica115:7-14.